Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nanomedicine

• Publication date

  2013-06-25

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.2217/nnm.12.141PMID 23075315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.

  2012cited by this paper
• Effect of Surfactant on Characteristics of Solid Lipid Nanoparticles (SLN)

  2011cited by this paper
• Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation.

  2011cited by this paper
• Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery

  2011cited by this paper
• Therapeutic effect of chitosan modification on salmon-calcitonin-loaded PLGA nanoparticles

  2011cited by this paper
• Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions.

  2011cited by this paper
• The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process

  2011cited by this paper
• Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles.

  2010cited by this paper
• In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes.

  2010cited by this paper
• Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery.

  2010cited by this paper
• Therapeutic application of peptides and proteins: parenteral forever?

  2009cited by this paper
• Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size.

  2009cited by this paper
• Preparation of solid lipid nanoparticles from W/O/W emulsions: Preliminary studies on insulin encapsulation

  2009cited by this paper
• Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization.

  2008cited by this paper
• Solid lipid nanoparticles for pulmonary delivery of insulin.

  2008cited by this paper
• Development of Nitrendipine Controlled Release Formulations Based on SLN and NLC for Topical Delivery: In Vitro and Ex Vivo Characterization

  2008cited by this paper
• Stability of lipid excipients in solid lipid nanoparticles.

  2007cited by this paper
• Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.

  2007cited by this paper
• Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles.

  2007cited by this paper
• Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives

  2007cited by this paper
• Sodium dodecyl sulfate promoting a cooperative association process of sodium cholate with bovine serum albumin.

  2006cited by this paper
• Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.

  2006cited by this paper
• Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.

  2006cited by this paper
• Aqueous-Soluble, Non-Reversible Lipid Conjugate of Salmon Calcitonin: Synthesis, Characterization and In Vivo Activity

  2006cited by this paper
• Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.

  2005cited by this paper
• A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.

  2005cited by this paper
• Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

  2005cited by this paper
• Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts.

  2005cited by this paper
• Estimation of the Increase in Solubility of Drugs as a Function of Bile Salt Concentration

  2004cited by this paper
• Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles.

  2004cited by this paper
• Reversible lipidization for the oral delivery of salmon calcitonin.

  2003cited by this paper
• Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)--effect of surfactants, storage time and crystallinity.

  2002cited by this paper
• Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells.

  2001cited by this paper
• Oral delivery of salmon calcitonin.

  2000cited by this paper
• Thymopentin in solid lipid nanoparticles

  1996cited by this paper
• Aggregation behavior of bile salts in aqueous solution.

  1996cited by this paper
• Biodegradation of solid lipid nanoparticles as a function of lipase incubation time

  1996cited by this paper
• Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats.

  1995cited by this paper
• Temperature effect on endocytosis and exocytosis by rabbit alveolar macrophages.

  1989cited by this paper
• The influence of bile salt structure on self-association in aqueous solutions.

  1983cited by this paper

• Biomimetic chitosan derivatives inspired by cell-penetrating peptides for enhanced octreotide absorption following lung delivery.

  2025cites this paper
• Sodium versus ammonium salts of a poorly water-soluble API using sparfloxacin - physicochemical and biological properties.

  2025cites this paper
• Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats

  2025cites this paper
• Revolutionizing transdermal drug delivery: unveiling the potential of cubosomes and ethosomes.

  2024cites this paper
• Utilizing nanomaterials for cancer treatment and diagnosis: an overview

  2024cites this paper
• Unravelling the role of solid lipid nanoparticles in drug delivery: Journey from laboratory to clinical trial

  2023cites this paper
• Preparation, characterization, and pharmacological application of oral Honokiol-loaded solid lipid nanoparticles for diabetic neuropathy.

  2023cites this paper
• Lipid based drug delivery systems for oral, transdermal and parenteral delivery: Recent strategies for targeted delivery consistent with different clinical application

  2023cites this paper
• Lipid nanoparticles in topical dermal drug delivery: Does chemistry of lipid persuade skin penetration?

  2022cites this paper
• Oral delivery of calcitonin-ion pairs: In vivo proof of concept for a highly lipophilic counterion.

  2022cites this paper
• A spotlight on alkaloid nanoformulations for the treatment of lung cancer

  2022cites this paper
• Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model

  2022cites this paper
• Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats

  2022cites this paper
• Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.

  2022cites this paper
• Novel Formulations and Drug Delivery Systems to Administer Biological Solids.

  2021cites this paper
• Current approaches in lipid-based nanocarriers for oral drug delivery

  2021cites this paper
• Efficient Delivery of Hydrophilic Small Molecules to Retinal Cell Lines Using Gel Core-Containing Solid Lipid Nanoparticles

  2021cites this paper
• Efficient Hydrophilic Small Molecule Delivery To Retinal Cell

  2021cites this paper
• [Construction of Oral Insulin-Loaded Solid Lipid Nanoparticles and Their Intestinal Epithelial Cell Transcytosis Study].

  2021cites this paper
• A nanoemulsion/micelles mixed nanosystem for the oral administration of hydrophobically modified insulin

  2021cites this paper
• Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes.

  2020cites this paper
• DDDT_A_233023 2355..2370

  2020cites this paper
• Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects

  2020cites this paper
• Solid Lipid Microparticles for Oral Delivery of Catalase: Focus on the Protein Structural Integrity and Gastric Protection

  2020cites this paper
• A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity

  2020cites this paper
• Insights on Ultrafiltration-Based Separation for the Purification and Quantification of Methotrexate in Nanocarriers

  2020cites this paper
• Flash Fabrication of Orally Targeted Nanocomplexes for Improved Transport of Salmon Calcitonin across the Intestine.

  2020cites this paper
• Lipid-Based Nanoparticles for Drug-Delivery Systems

  2019cites this paper
• Design strategies for chemical-stimuli-responsive programmable nanotherapeutics.

  2019cites this paper
• Enhancement of oral bioavailability of salmon calcitonin through chitosan‐modified, dual drug‐loaded nanoparticles

  2019cites this paper
• Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability

  2019influential citation
• Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia

  2019cites this paper
• Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs

  2019cites this paper
• Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool.

  2019cites this paper
• Preparation and characterization of solid lipid nanoparticles loaded with salmon calcitonin phospholipid complex

  2019cites this paper
• Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles.

  2019cites this paper
• Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles

  2019cites this paper
• Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.

  2018cites this paper
• PEG‐PGA enveloped octaarginine‐peptide nanocomplexes: An oral peptide delivery strategy

  2018cites this paper
• Lipid-based nanosuspensions for oral delivery of peptides, a critical review.

  2018cites this paper
• Design strategies for physical-stimuli-responsive programmable nanotherapeutics.

  2018cites this paper
• Advances on the formulation of proteins using nanotechnologies

  2017cites this paper
• Lipophilic peptide character - What oral barriers fear the most.

  2017cites this paper
• Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.

  2017cites this paper
• Size-Dependent Translocation of Nanoemulsions via Oral Delivery.

  2017cites this paper
• Role of Nanoparticles in Drug Delivery and Regenerative Therapy for Bone Diseases.

  2017cites this paper
• Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers

  2017cites this paper
• Development of nanomaterials for bone-targeted drug delivery.

  2017cites this paper
• Development and evaluation of lipid-based oral delivery systems for oxyresveratrol

  2016cites this paper
• Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System.

  2016cites this paper
• Lipid-based nanocarriers for oral peptide delivery.

  2016influential citation
• New perspectives in oral peptide and protein delivery: from nanocarrier design to in vivo effectiveness

  2016cites this paper
• Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.

  2016cites this paper
• Lipid-based nanoformulations for peptide delivery.

  2016cites this paper
• Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.

  2016cites this paper
• Improved oral bioavailability of bioactives through lipid-based nanoarchitectures**Declaration of Interest: The authors report no conflict of interest.

  2016cites this paper
• Nanocarriers for delivery of biotherapeutics to intestinal mucosa

  2015cites this paper
• Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs.

  2015cites this paper
• Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles.

  2015cites this paper
• Efficient Peroral Delivery of Insulin via Vitamin B12 Modified Trimethyl Chitosan Nanoparticles.

  2015cites this paper
• Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers.

  2015cites this paper
• Are caveolae a cellular entry route for non-viral therapeutic delivery systems?

  2015cites this paper
• Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery.

  2015cites this paper
• Comparison of the oral bioavailability of silymarin-loaded lipid nanoparticles with their artificial lipolysate counterparts: implications on the contribution of integral structure.

  2015cites this paper
• Enhanced bioavailability of tripterine through lipid nanoparticles using broccoli-derived lipids as a carrier material.

  2015cites this paper
• Exendin-4 Loaded Nanoparticles with a Lipid Shell and Aqueous Core Containing Micelles for Enhanced Intestinal Absorption.

  2015cites this paper
• Solid lipid nanoparticles for hydrophilic biotech drugs: optimization and cell viability studies (Caco-2 & HEPG-2 cell lines).

  2014cites this paper
• Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation

  2014cites this paper
• Physicochemical and Formulation Developability Assessment for Therapeutic Peptide Delivery—A Primer

  2014cites this paper
• Drug carriers for the delivery of therapeutic peptides.

  2014cites this paper
• Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.

  2014influential citation
• Erratum to: Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation

  2014cites this paper
• Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives.

  2014cites this paper
• Formulation strategies to improve oral peptide delivery.

  2014cites this paper
• Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.

  2013cites this paper